Show simple item record

dc.contributor.advisorPelletier, Michel
dc.contributor.authorSerbonich, Matthew
dc.date.accessioned2021-09-08T14:16:35Z
dc.date.available2021-09-08T14:16:35Z
dc.date.issued5/17/2018
dc.identifier.urihttp://hdl.handle.net/20.500.12648/6704
dc.description.abstractTrypanosoma brucei, the causative agent of human African trypanosomiasis, also known as African sleeping sickness, expresses a protein known as TbLpn which plays a critical role in arginine methylation and phospholipid synthesis within T. brucei. In order to determine the effect and potential medical benefits of downregulated TbLpn expression in T. brucei, RNA interference was used by transfecting T. brucei with plasmid DNA through electroporation. After conducting this experimental protocol, T. brucei was unable to be grown successfully in media following transfection and the effect of downregulated TbLpn in T. brucei requires further investigation in order to determine its potential for developing new drug targets and treatment methods for human African trypanosomiasis. Experimental protocol changes and repetition and verification of the validity of current protocols could lead the way for successful growth of T. brucei with downregulated TbLpn.
dc.subjectTrypansoma Brucei
dc.subjectAfrican Sleeping Sickness
dc.subjectTsetse Fly
dc.subjectPhospholipids Biosynthesis
dc.titleDisruption of TbLpn Expression in T. brucei by RNA Interference
dc.typethesis
refterms.dateFOA2021-09-08T14:16:35Z
dc.description.institutionSUNY Brockport
dc.description.departmentBiology
dc.source.statuspublished
dc.description.publicationtitleSenior Honors Theses
dc.contributor.organizationThe College at Brockport
dc.languate.isoen_US


Files in this item

Thumbnail
Name:
honors/218/fulltext (1).pdf
Size:
480.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record